Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Arcus Biosciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Pharmaceutical Preparations
Prev close 24.28 · gapped below the open, never looked back. High/low 24.28 at 3:45 pm ET, 23.40 at 10:45 am ET.
232 institutional managers report a position in Arcus Biosciences, Inc. worth $3.8B between them, filed on form 13F for the quarter ending 2026-06-30. 19 of them hold 80% of it, the largest being Gilead Sciences Inc at 25.52%.
207 more managers in the register
19 managers hold 80% of the $3.8B institutional base. The other 213 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
RCUS (Arcus Biosciences, Inc.) has 5 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: AZN −1.27%, in industrials & materials.
via Gilead Sciences Inc, Woodline Partners LP, Parkman Healthcare Partners LLC +1 more · 25.52% of RCUS, 26.48% of ASMB
via Gilead Sciences Inc, DAFNA Capital Management LLC · 25.52% of RCUS, 51.36% of LKFT
via Gilead Sciences Inc, Woodline Partners LP, Wellington Management Group LLP · 25.52% of RCUS, 10.88% of KYTX
via Wellington Management Group LLP, BNP Paribas Investment Partners S.A., Siren, L.L.C. +7 more · 4.79% of RCUS, 5.76% of CRNX
via Wellington Management Group LLP, Suvretta Capital Management, LLC, Soleus Capital Management, L.P. +3 more · 4.79% of RCUS, 5.00% of AVLN
via Wellington Management Group LLP, Woodline Partners LP, Marshall Wace LLP +4 more · 4.79% of RCUS, 3.78% of TRVI
Managers holding a meaningful stake in RCUS also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.